Entacapone Teva 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued 2 / 
affected 3  
amended 
on 
N/0018 
Minor change in labelling or package leaflet not 
10/09/2021 
PL 
connected with the SPC (Art. 61.3 Notification) 
IA/0017 
A.7 - Administrative change - Deletion of 
01/02/2021 
Annex II and PL 
manufacturing sites 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are 
issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD 
is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
IA/0016/G 
This was an application for a group of variations. 
23/08/2019 
n/a 
B.III.1.a.2 - Submission of a new/updated or deletion 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Eur. Monograph - Updated certificate from an already 
approved manufacturer 
B.III.1.a.2 - Submission of a new/updated or deletion 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Eur. Monograph - Updated certificate from an already 
approved manufacturer 
N/0015 
Minor change in labelling or package leaflet not 
14/11/2018 
Labelling 
connected with the SPC (Art. 61.3 Notification) 
IA/0014/G 
This was an application for a group of variations. 
31/05/2018 
n/a 
B.II.e.4.a - Change in shape or dimensions of the 
container or closure (immediate packaging) - 
Non-sterile medicinal products 
B.III.1.a.2 - Submission of a new/updated or deletion 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Eur. Monograph - Updated certificate from an already 
approved manufacturer 
IA/0013 
B.III.1.a.2 - Submission of a new/updated or deletion 
10/10/2016 
n/a 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Eur. Monograph - Updated certificate from an already 
approved manufacturer 
IA/0012 
B.III.1.a.2 - Submission of a new/updated or deletion 
24/06/2016 
n/a 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Page 2/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eur. Monograph - Updated certificate from an already 
approved manufacturer 
IA/0011 
A.7 - Administrative change - Deletion of 
30/03/2016 
20/03/2017 
Annex II and PL 
manufacturing sites 
R/0010 
Renewal of the marketing authorisation. 
24/09/2015 
19/11/2015 
SmPC, Annex 
Based on the review of the available information the CHMP is 
II, Labelling 
of the opinion that the quality, the safety and the efficacy of 
and PL 
this medicinal product continues to be adequately and 
sufficiently demonstrated and therefore considers that the 
benefit/risk profile of Entacapone Teva continues to be 
favourable. The CHMP is of the opinion that the renewal can 
be granted with unlimited validity. 
T/0009 
Transfer of Marketing Authorisation 
30/09/2014 
27/10/2014 
SmPC, 
Labelling and 
PL 
IB/0008 
B.I.d.1.z - Stability of AS - Change in the re-test 
16/07/2014 
n/a 
period/storage period or storage conditions - Other 
variation 
IAIN/0007 
B.III.1.a.3 - Submission of a new/updated or deletion 
26/06/2014 
n/a 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Eur. Monograph - New certificate from a new 
manufacturer (replacement or addition) 
IAIN/0006 
B.III.1.a.1 - Submission of a new/updated or deletion 
18/03/2014 
n/a 
of Ph. Eur. Certificate of Suitability to the relevant Ph. 
Eur. Monograph - New certificate from an already 
approved manufacturer 
Page 3/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N/0005 
Minor change in labelling or package leaflet not 
20/02/2014 
21/03/2014 
PL 
connected with the SPC (Art. 61.3 Notification) 
IAIN/0004 
C.I.z - Changes (Safety/Efficacy) of Human and 
21/05/2013 
n/a 
Veterinary Medicinal Products - Other variation 
IB/0003 
C.I.2.a - Change in the SPC, Labelling or PL of a 
04/03/2013 
21/03/2014 
SmPC, Annex 
The Applicant proposes to update the Product Information to 
generic/hybrid/biosimilar products following 
II, Labelling 
incorporate the below discussed safety updates adopted for 
assessment of the same change for the reference 
and PL 
the reference product Comtess through a work sharing 
product - Implementation of change(s) for which NO 
new additional data are submitted by the MAH 
IB/0001/G 
This was an application for a group of variations. 
12/03/2012 
n/a 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold increase 
compared to the currently approved batch size 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process of 
the AS 
B.III.2.a.1 - Change of specification('s) of a former 
procedure EMEA/H/C/xxxx/WS/0331 and aligment with the 
revised QRD template (version 8). 
The safety update consist of updates to sections 4.4 and 4.8 
of the SmPC to implement a class labelling on the risk of 
impulse control disorder and consequential changes to 
sections 2 and 4 of the Package Leaflet. 
In addition, alignment in accordance with the requirements 
set out in the list of Union Reference Dates (EURD list) have 
been made in Annex II. 
The Applicant would also like to take the opportunity to 
propose some minor amendments to the translated Product 
Information in some languages due to readability and 
compliance with the reference product text. 
Page 4/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
non Pharmacopoeial substance to comply with the Ph. 
Eur. or with a national pharmacopoeia of a Member 
State - AS 
B.I.d.1.z - Stability of AS - Change in the re-test 
period/storage period or storage conditions - Other 
variation 
IAIN/0002 
A.5.a - Administrative change - Change in the name 
23/01/2012 
10/09/2012 
Annex II and PL 
and/or address of a manufacturer responsible for 
batch release 
Page 5/5 
 
 
 
 
 
 
 
 
 
